| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $182,410 | 2 | 17 |
Sells | $651,007 | 10 | 83 |
| Lochner Daniel | Chief Financial Officer | 1 | $129,660 | 0 | $0 | $129,660 |
| REICIN ALISE | Chief Executive Officer | 1 | $52,750 | 0 | $0 | $52,750 |
| McNamara Peter | Chief Scientific Officer | 0 | $0 | 7 | $288,007 | $-288,007 |
| Ruddy Marcella K. | Chief Medical Officer | 0 | $0 | 3 | $363,000 | $-363,000 |
Tectonic Therapeutic, Inc. operates as a clinical-stage biotechnology firm dedicated to the identification and progression of biologic therapies, primarily therapeutic proteins and antibodies, that regulate the function of G-protein coupled receptors (GPCRs). The company leverages its proprietary GEODe technology platform to facilitate the discovery and development of these GPCR-targeted medicines. Its robust pipeline includes an RXFP1 agonist, currently undergoing Phase 1a and 1b clinical trials for the treatment of heart failure with …
Over the last 12 months, insiders at Tectonic Therapeutic, Inc. have bought $182,410 and sold $651,007 worth of Tectonic Therapeutic, Inc. stock.
On average, over the past 5 years, insiders at Tectonic Therapeutic, Inc. have bought $20.93M and sold $4.6M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Lochner Daniel (Chief Financial Officer) — $129,660. REICIN ALISE (Chief Executive Officer) — $52,750.
The last purchase of 2,500 shares for transaction amount of $52,750 was made by REICIN ALISE (Chief Executive Officer) on 2026‑02‑11.
| 2026-09-30 | Sale | McNamara Peter | Chief Scientific Officer | 536 0.0028% | $23.04 | $12,349 | -8.87% | |
| 2026-08-25 | Sale | McNamara Peter | Chief Scientific Officer | 43 0.0002% | $36.52 | $1,570 | -38.13% | |
| 2026-08-12 | Sale | McNamara Peter | Chief Scientific Officer | 43 0.0002% | $35.00 | $1,505 | -33.34% | |
| 2026-06-30 | Sale | McNamara Peter | Chief Scientific Officer | 172 0.0009% | $35.00 | $6,020 | -13.80% | |
| 2026-05-04 | Sale | Ruddy Marcella K. | Chief Medical Officer | 1,065 0.0057% | $30.00 | $31,950 | -1.05% | |
| 2026-04-01 | Sale | Ruddy Marcella K. | Chief Medical Officer | 1,000 0.0054% | $31.05 | $31,050 | -4.68% | |
| 2026-03-06 | Sale | Ruddy Marcella K. | Chief Medical Officer | 10,000 0.0447% | $30.00 | $300,000 | -17.26% | |
| 2026-03-06 | Sale | McNamara Peter | Chief Scientific Officer | 6,262 0.0281% | $30.17 | $188,935 | -17.26% | |
| 2026-03-04 | Sale | McNamara Peter | Chief Scientific Officer | 1,650 0.008% | $25.00 | $41,250 | +8.28% | |
| 2026-03-03 | Sale | McNamara Peter | Chief Scientific Officer | 1,649 0.0085% | $22.06 | $36,377 | +21.58% | |
| 2026-02-11 | REICIN ALISE | Chief Executive Officer | 2,500 0.0128% | $21.10 | $52,750 | +33.35% | ||
| 2026-02-10 | Lochner Daniel | Chief Financial Officer | 6,000 0.0329% | $21.61 | $129,660 | +39.41% | ||
| 2025-04-11 | SPRINGER TIMOTHY A | 63,184 0.2587% | $16.31 | $1.03M | +29.21% | |||
| 2025-04-10 | SPRINGER TIMOTHY A | 53,950 0.2266% | $16.73 | $902,584 | +25.12% | |||
| 2025-04-09 | SPRINGER TIMOTHY A | 24,789 0.0918% | $14.76 | $365,900 | +23.87% | |||
| 2025-04-07 | Sale | MCGUIRE TERRANCE | director | 500,000 2.1462% | $17.10 | $8.55M | +33.77% | |
| 2025-04-07 | SPRINGER TIMOTHY A | 500,000 2.1462% | $17.10 | $8.55M | +33.77% | |||
| 2025-02-05 | SPRINGER TIMOTHY A | 789,294 10.0406% | $50.68 | $40M | -56.18% | |||
| 2025-02-05 | Lochner Daniel | Chief Financial Officer | 4,617 0.0627% | $54.14 | $249,964 | -56.18% | ||
| 2024-10-22 | SPRINGER TIMOTHY A | 300,000 2.5295% | $33.59 | $10.08M | -37.83% |
| REICIN ALISE | Chief Executive Officer | 127030 0.6498% | $2.41M | 1 | 0 | |
| Lochner Daniel | Chief Financial Officer | 32044 0.1639% | $608,195.12 | 2 | 0 | <0.0001% |
| SPRINGER TIMOTHY A | 4334846 22.1738% | $82.28M | 7 | 0 | +0.03% |
$31,123,523 | 108 | 6.46% | $387.86M | |
$24,384,691 | 42 | -30.27% | $396.82M | |
$22,020,194 | 25 | 38.25% | $405.58M | |
$2,471,510 | 19 | 17.33% | $334.18M | |
$57,263,116 | 11 | -8.37% | $386.95M |
| Increased Positions | 66 | +60.55% | 4M | +35.29% |
| Decreased Positions | 47 | -43.12% | 3M | -21.13% |
| New Positions | 31 | New | 2M | New |
| Sold Out Positions | 23 | Sold Out | 2M | Sold Out |
| Total Postitions | 128 | +17.43% | 14M | +14.16% |